Publication Cover
Biofouling
The Journal of Bioadhesion and Biofilm Research
Volume 32, 2016 - Issue 3
498
Views
17
CrossRef citations to date
0
Altmetric
Articles

Impact of Delftia tsuruhatensis and Achromobacter xylosoxidans on Escherichia coli dual-species biofilms treated with antibiotic agents

, , , &
Pages 227-241 | Received 13 Jul 2015, Accepted 18 Nov 2015, Published online: 22 Feb 2016

References

  • Al-Bakri AG, Gilbert P, Allison DG. 2005. Influence of gentamicin and tobramycin on binary biofilm formation by co-cultures of Burkholderia cepacia and Pseudomonas aeruginosa. J Basic Microbiol. 45:392–396. doi:10.1002/(ISSN)1521-4028.
  • Almeida C, Azevedo NF, Bento JC, Cerca N, Ramos H, Vieira MJ, Keevil CW. 2013. Rapid detection of urinary tract infections caused by Proteus spp. using PNA-FISH. Eur J Clin Microbiol. 32:781–786. doi:10.1007/s10096-012-1808-2.
  • Armbruster CE, Smith SN, Yep A, Mobley HL. 2014. Increased incidence of urolithiasis and bacteremia during Proteus mirabilis and Providencia stuartii coinfection due to synergistic induction of urease activity. J Infect Dis. 209:1524–1532. doi:10.1093/infdis/jit663.
  • Azevedo AS, Almeida C, Melo LF, Azevedo NF. 2014. Interaction between atypical microorganisms and E. coli in catheter-associated urinary tract biofilms. Biofouling. 30:893–902. doi:10.1080/08927014.2014.944173.
  • Azevedo AS, Almeida C, Pereira B, Madureira P, Wengel J, Azevedo NF. 2015. Detection and discrimination of biofilm populations using locked nucleic acid/2′-O-methyl-RNA fluorescence in situ hybridization (LNA/2′OMe-FISH). Biochemi Eng J. 104:64–73. doi:10.1016/j.bej.2015.04.024.
  • Azevedo NF, Pacheco AP, Keevil CW, Vieira MJ. 2006. Adhesion of water stressed Helicobacter pylori to abiotic surfaces. J Appl Microbiol. 101:718–724. doi:10.1111/jam.2006.101.issue-3.
  • Baldan R, Cigana C, Testa F, Bianconi I, De Simone M, Pellin D, Di Serio C, Bragonzi A, Cirillo DM. 2014. Adaptation of Pseudomonas aeruginosa in cystic fibrosis airways influences virulence of Staphylococcus aureus in vitro and murine models of co-infection. PLoS One. 9:e89614. doi:10.1371/journal.pone.0089614.
  • Brooks T, Keevil CW. 1997. A simple artificial urine for the growth of urinary pathogens. Lett Appl Microbiol. 24:203–206. doi:10.1046/j.1472-765X.1997.00378.x.
  • Broszat M, Grohmann E. 2014. Antibiofilm agents. Heidelberg: Springer. Chapter 5, Horizontal gene transfer in planktonic and biofilm modes; p. 67–95.
  • Burmolle M, Webb JS, Rao D, Hansen LH, Sorensen SJ, Kjelleberg S. 2006. Enhanced biofilm formation and increased resistance to antimicrobial agents and bacterial invasion are caused by synergistic interactions in multispecies biofilms. Appl Environ Microbiol. 72:3916–3923. doi:10.1128/AEM.03022-05.
  • Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. 1999. The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 37:1771–1776.
  • Cerqueira L, Oliveira JA, Nicolau A, Azevedo NF, Vieira MJ. 2013. Biofilm formation with mixed cultures of Pseudomonas aeruginosa/Escherichia coli on silicone using artificial urine to mimic urinary catheters. Biofouling. 29:829–840. doi:10.1080/08927014.2013.807913.
  • Ciofu O, Høiby N. 2008. Cystic fibrosis – coping with resistance. In: Gould IM, van der Meer JWM, editors. Antibiotic policies: fighting resistance. New York: Springer; p. 149–174.
  • Dellimore KH, Helyer AR, Franklin SE. 2013. A scoping review of important urinary catheter induced complications. Journal of Materials Science: Materials in Medicine. 24:1825–1835. doi:10.1007/s10856-013-4953-y.
  • Duetz WA. 2007. Microtiter plates as mini-bioreactors: miniaturization of fermentation methods. Trends Microbiol. 15:469–475. doi:10.1016/j.tim.2007.09.004.
  • Elias S, Banin E. 2012. Multi-species biofilms: living with friendly neighbors. FEMS Microbiol Rev. 36:990–1004. doi:10.1111/j.1574-6976.2012.00325.x.
  • Fenice M, Gallo A, Juarez-Jimenez B, Gonzalez-Lopez J. 2007. Screening for extracellular enzyme activities by bacteria isolated from samples collected in the Tyrrhenian Sea. Ann Microbiol. 57:93–99. doi:10.1007/BF03175056.
  • Foster KR. 2011. The secret social lives of microorganisms. Microbe. 6:183–186.
  • Frank DN, Wilson SS, St Amand AL, Pace NR. 2009. Culture-independent microbiological analysis of foley urinary catheter biofilms. PLoS One. 4:e7811. doi:10.1371/journal.pone.0007811.
  • Ghigo JM. 2001. Natural conjugative plasmids induce bacterial biofilm development. Nature. 412:442–445. doi:10.1038/35086581.
  • Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. 2010. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 35:322–332. doi:10.1016/j.ijantimicag.2009.12.011.
  • Hola V, Ruzicka F, Horka M. 2010. Microbial diversity in biofilm infections of the urinary tract with the use of sonication techniques. FEMS Immunol MedMicrobiol. 59:525–528. doi:10.1111/j.1574-695X.2010.00703.x.
  • Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, Saint S, Schaeffer AJ, Tambayh PA, Tenke P, et al. 2010. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 50:625–663. doi:10.1086/650482.
  • Jacobsen SM, Stickler DJ, Mobley HL, Shirtliff ME. 2008. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev. 21:26–59. doi:10.1128/CMR.00019-07.
  • Kara D, Luppens SB, Cate JM. 2006. Differences between single- and dual-species biofilms of Streptococcus mutans and Veillonella parvula in growth, acidogenicity and susceptibility to chlorhexidine. Eur J Oral Sci. 114:58–63. doi:10.1111/eos.2006.114.issue-1.
  • Kline KA, Schwartz DJ, Gilbert NM, Hultgren SJ, Lewis AL. 2012. Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli. Infect Immun. 80:4186–4194. doi:10.1128/IAI.00684-12.
  • Klinth JE, Castelain M, Uhlin BE, Axner O. 2012. The influence of pH on the specific adhesion of P piliated Escherichia coli. PLoS One. 7:e38548. doi:10.1371/journal.pone.0038548.
  • Kohanski MA, Dwyer DJ, Collins JJ. 2010. How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol. 8:423–435. doi:10.1038/nrmicro2333.
  • Kostaki M, Chorianopoulos N, Braxou E, Nychas GJ, Giaouris E. 2012. Differential biofilm formation and chemical disinfection resistance of sessile cells of listeria monocytogenes strains under monospecies and dual-species (with Salmonella enterica) conditions. Appl Environ Microbiol. 78:2586–2595. doi:10.1128/AEM.07099-11.
  • Kumar S, Wittmann C, Heinzle E. 2004. Review: Minibioreactors. Biotechnol Lett. 26:1–10. doi:10.1023/B:BILE.0000009469.69116.03.
  • Lawrence EL, Turner IG. 2005. Materials for urinary catheters: a review of their history and development in the UK. Med Eng Phys. 27:443–453. doi:10.1016/j.medengphy.2004.12.013.
  • Lee KW, Periasamy S, Mukherjee M, Xie C, Kjelleberg S, Rice SA. 2014. Biofilm development and enhanced stress resistance of a model, mixed-species community biofilm. ISME J. 8:894–907. doi:10.1038/ismej.2013.194.
  • Lenski RE, Rose MR, Simpson SC, Tadler SC. 1991. Long-term experimental evolution in Escherichia coli. I. Adaptation and divergence during 2,000 generations. Am Nat. 138:1315–1341. doi:10.1086/an.1991.138.issue-6.
  • Leriche V, Briandet R, Carpentier B. 2003. Ecology of mixed biofilms subjected daily to a chlorinated alkaline solution: spatial distribution of bacterial species suggests a protective effect of one species to another. Environ Microbiol. 5:64–71. doi:10.1046/j.1462-2920.2003.00394.x.
  • Lopes SP, Azevedo NF, Pereira MO. 2014. Emergent bacteria in cystic fibrosis: in vitro biofilm formation and resilience under variable oxygen conditions. Biomed Res Int. 2014:678301. doi:10.1155/2014/678301.
  • Lopes SP, Azevedo NF, Pereira MO. 2015. Microbiome in cystic fibrosis: shaping polymicrobial interactions for advances in antibiotic therapy. Crit Rev Microbiol. 41:353–365. doi:10.3109/1040841X.2013.847898.
  • Lopes SP, Ceri H, Azevedo NF, Pereira MO. 2012. Antibiotic resistance of mixed biofilms in cystic fibrosis: impact of emerging microorganisms on treatment of infection. Int J Antimicrob Agents. 40:260–263. doi:10.1016/j.ijantimicag.2012.04.020.
  • Lyczak JB, Cannon CL, Pier GB. 2002. Lung infections associated with cystic fibrosis. Clin Microbiol Rev. 15:194–222. doi:10.1128/CMR.15.2.194-222.2002.
  • May T, Ito A, Okabe S. 2009. Induction of multidrug resistance mechanism in Escherichia coli biofilms by interplay between tetracycline and ampicillin resistance genes. Antimicrob Agents Chemother. 53:4628–4639. doi:10.1128/AAC.00454-09.
  • Nicolle LE. 2005. Catheter-related urinary tract infection. Drugs Aging. 22:627–639. doi:10.2165/00002512-200522080-00001.
  • Niveditha S, Pramodhini S, Umadevi S, Kumar S, Stephen S. 2012. The isolation and the biofilm formation of uropathogens in the patients with catheter associated urinary tract infections (UTIs). J Clin Diagn Res. 6:1478–1482. doi:10.7860/JCDR/2012/4367.2537.
  • Perlin MH, Clark DR, McKenzie C, Patel H, Jackson N, Kormanik C, Powell C, Bajorek A, Myers DA, Dugatkin LA, et al. 2009. Protection of Salmonella by ampicillin-resistant Escherichia coli in the presence of otherwise lethal drug concentrations. Proc Biol Sci. 276:3759–3768. doi:10.1098/rspb.2009.0997.
  • Raffi HS, Bates JM, Flournoy DJ, Kumar S. 2012. Tamm-Horsfall protein facilitates catheter associated urinary tract infection. BMC Res Notes. 5:532. doi:10.1186/1756-0500-5-532.
  • Reinecke F, Groth T, Heise KP, Joentgen W, Muller N, Steinbuchel A. 2000. Isolation and characterization of an Achromobacter xylosoxidans strain B3 and other bacteria capable to degrade the synthetic chelating agent iminodisuccinate. FEMS Microbiol Lett. 188:41–46. doi:10.1111/fml.2000.188.issue-1.
  • Ronald A. 2002. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med. 113:14–19. doi:10.1016/S0002-9343(02)01055-0.
  • Savage VJ, Chopra I, O’Neill AJ. 2013. Staphylococcus aureus biofilms promote horizontal transfer of antibiotic resistance. Antimicrob Agents Chemother. 57:1968–1970. doi:10.1128/AAC.02008-12.
  • Siener R, Jahnen A, Hesse A. 2004. Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization. Eur J Clin Nutr. 58:270–276. doi:10.1038/sj.ejcn.1601778.
  • Simoes M, Simoes LC, Vieira MJ. 2009. Species association increases biofilm resistance to chemical and mechanical treatments. Water Res. 43:229–237. doi:10.1016/j.watres.2008.10.010.
  • Spadafino JT, Cohen B, Liu J, Larson E. 2014. Temporal trends and risk factors for extended-spectrum beta-lactamase-producing Escherichia coli in adults with catheter-associated urinary tract infections. Antimicrob Resist Infect Control. 3:39. doi:10.1186/s13756-014-0039-y.
  • Steinman MA, Gonzales R, Linder JA, Landefeld CS. 2003. Changing use of antibiotics in community-based outpatient practice, 1991-1999. Ann Intern Med. 138:525–533. doi:10.7326/0003-4819-138-7-200304010-00008.
  • Stickler DJ. 2008. Bacterial biofilms in patients with indwelling urinary catheters. Nat Clin Pract Urol. 5:598–608. doi:10.1038/ncpuro1231.
  • Wu S, Li X, Gunawardana M, Maguire K, Guerrero-Given D, Schaudinn C, Wang C, Baum MM, Webster P. 2014. Beta-lactam antibiotics stimulate biofilm formation in non-typeable haemophilus influenzae by up-regulating carbohydrate metabolism. PLoS One. 9:e99204. doi:10.1371/journal.pone.0099204.
  • Yurtsev EA, Chao HX, Datta MS, Artemova T, Gore J. 2013. Bacterial cheating drives the population dynamics of cooperative antibiotic resistance plasmids. Mol Syst Biol. 9:683. doi:10.1038/msb.2013.39.
  • Zhanel GG, Karlowsky JA, Harding GK, Carrie A, Mazzulli T, Low DE, Hoban DJ. 2000. A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob Agents Chemother. 44:1089–1092. doi:10.1128/AAC.44.4.1089-1092.2000.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.